INSIGHTS ON DRUG DEVELOPMENT

• Futurizing Healthcare By Localizing The Life Sciences

  Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.

• The Art Of Protein Expression: A Guide To Understanding Difficult-To-Express Proteins

  Protein expression failures often result from misfolding, PTMs, assembly issues, insolubility, and toxicity. Understanding their interplay can improve yields.

• Thunderstruck By Antibody-Drug Conjugates

  Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

• How Lipid Nanoparticles Enable Next-Gen Delivery

  Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.

• Formulation And Process Challenges For A Needle-Shaped API

  9/28/2026

  Managing challenging active pharmaceutical ingredient crystal structures and choosing dry granulation over wet granulation requires strategic processing choices.

• A Simple And Powerful Solution For Accelerating Dissolution

  5/5/2026

  Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.

• Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights

  3/5/2025

  Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.

• Quantifying Endotoxins Via Absorbance Or Fluorescence

  3/20/2026

  Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.

• Navigating Nitrosamine Impurities In Pharmaceutical Drug Development

  3/3/2026

  Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.